AU - Erfanian, Nafiseh AU - Miri-Moghaddam, Ebrahim TI - Treatment of COVID-19 patients using plasma therapy: Letter to Editor PT - JOURNAL ARTICLE TA - Yektaweb JN - Yektaweb VO - 28 VI - 1 IP - 1 4099 - http://journal.bums.ac.ir/article-1-2929-en.html 4100 - http://journal.bums.ac.ir/article-1-2929-en.pdf SO - Yektaweb 1 ABĀ  - The symptoms of COVID-19, caused by the newly known type of coronavirus, vary widely from asymptomatic, mild to severe respiratory infection leading to hospitalization or death of patients. To date, no specific drug has been reported for the treatment of patients affected by this virus. One of the approaches adopted for the treatment of this disease is the use of plasma therapy, which contains antibodies against the virus. Following of the plasma therapy have not been reported any serious side effects. Currently, the numbers of these studies are limited, and evaluation of the larger population studies can provide stronger evidence for treating physicians about the effectiveness of this therapeutic approach. CP - IRAN IN - LG - eng PB - Yektaweb PG - 84 PT - Letter to Editor YR - 2021